Lifevantage Corporation
LFVN
Market Cap$156.47M
Close$
$13.88
9.9% upside
Current Fair Value
9.9% upsideUndervalued by 9.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $156.47 Million |
|---|---|
| Enterprise Value | $147.32 Million |
| Dividend Yield | $0.165 (1.32743362831858%) |
| Earnings per Share | $0.24 |
| Beta | 0.47 |
| Outstanding Shares | 12,350,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 16.78 |
|---|---|
| PEG | 15.37 |
| Price to Sales | 0.7 |
| Price to Book Ratio | 6.32 |
| Enterprise Value to Revenue | 0.66 |
| Enterprise Value to EBIT | 9.36 |
| Enterprise Value to Net Income | 12 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.39 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Lifevantage Corporation
CEO: Darren Jensen LifeVantage Corporation is a pioneer in Nutrigenomics - a new science dedicated to biohacking the human aging code. The Company engages in the identification, research, development and distribution of advanced nutraceutical dietary suppl...